Ziprasidone in Early Onset Schizophrenia Spectrum Disorders
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This is an open trial of ziprasidone (ZIP) in children and adolescents. It is designed to
provide pilot data on the magnitude of ZIP's antipsychotic effects in psychotic youth, dosing
ranges, acute safety, and tolerability. This would then inform the design of a rigorous,
randomized controlled trial of ZIP in the pediatric population. The primary study hypothesis
is that the proportion of pediatric subjects responding to treatment with ziprasidone will be
comparable or greater than reported in trials of ziprasidone in adults.